Multiple sclerosis treatment with stem cells is increasingly gaining attention as a potential approach to address this challenging autoimmune disease. Stem cells, known for their ability to regenerate and adapt, offer hope to those seeking innovative solutions for managing MS. In this article, we will explore the different types of stem cells used for treating MS, how they work, and the ongoing research that may shape the future of multiple sclerosis treatment.
What Are Stem Cells?
Stem cells are unspecialized cells capable of developing into many different types of cells, such as nerve cells or immune cells. These unique cells play a crucial role in growth, development, and repair, making them a promising focus for medical research and therapy. In the context of multiple sclerosis treatment with stem cells, researchers are investigating several types of stem cells, including mesenchymal stem cells, neural stem cells, and hematopoietic stem cells, to explore their therapeutic potential.
Hematopoietic Stem Cell Transplantation (aHSCT)
Autologous Hematopoietic Stem Cell Transplantation (aHSCT) is one of the most studied approaches for multiple sclerosis treatment with stem cells. This treatment involves harvesting hematopoietic stem cells (HSCs) from the patient’s own bone marrow. These HSCs are then stored, and the patient undergoes chemotherapy to significantly reduce the existing immune cells. After chemotherapy, the stored HSCs are reintroduced into the body to help rebuild a healthier immune system.
The goal of aHSCT is to “reformat” the immune system to stop inflammation in people with active MS. Although aHSCT can reduce relapses and new lesions, it is important to note that this treatment cannot regenerate damaged nerve cells in the spinal cord or other parts of the nervous system.
Who Is aHSCT Suitable For?
The evidence suggests that aHSCT is most beneficial for people with highly active relapsing MS who are under the age of 50 and in the earlier stages of the disease. Those with progressive forms of MS and higher levels of disability are less likely to benefit from aHSCT due to its risks, which include side effects from chemotherapy and potential complications.

Mesenchymal Stem Cell Therapy (MSC Therapy)
Mesenchymal Stem Cells (MSCs) are another type of adult stem cells that can differentiate into various cells, including nerve, muscle, and cartilage cells. MSC therapy aims to reduce the inflammation that contributes to MS by modulating the immune system. Unlike aHSCT, MSC therapy does not require chemotherapy, making it less invasive. Instead, MSCs are isolated from bone marrow, cultured in a lab, and infused into the patient.
Although MSC therapy holds promise, research is still in its early stages. Clinical trials so far have shown that mesenchymal stem cell therapy is safe, but there is not yet enough evidence to conclude its effectiveness in treating MS. The MESEMS trial, an international collaboration, found that MSC therapy was well-tolerated but did not significantly reduce inflammation in patients with active forms of MS.
Neural Stem Cells (NSCs) and Emerging Therapies
Neural stem cells are another promising avenue in multiple sclerosis treatment with stem cells. NSCs have the potential to differentiate into nerve cells and may help repair damaged nerves in the central nervous system. Recent studies have indicated that neural stem cell transplantation may protect the brain from further damage and potentially stabilize disease progression.
A collaborative study involving researchers from the University of Colorado, Cambridge, and Milano-Bicocca demonstrated the potential benefits of injecting NSCs into the brains of MS patients. The study found that this approach was safe and showed signs of preventing further disability progression. Though promising, these findings need further research to confirm their effectiveness and safety on a larger scale.
Benefits and Limitations of Stem Cell Therapy for MS
Stem cell therapy for MS, including aHSCT and MSC therapy, has shown potential benefits such as reducing relapses, slowing disease progression, and improving quality of life. However, these therapies are not without limitations. The following are some benefits and challenges associated with multiple sclerosis treatment with stem cells:
Benefits:
- Reduction of Inflammation: Stem cell therapies can help reduce inflammation, which is a significant factor in MS disease activity.
- Improvement in Neurological Function: Some patients undergoing aHSCT have reported improvements in neurological function, such as reduced disability and better cognitive function.
- Potential Regenerative Effects: Certain types of stem cells, like NSCs, show promise in potentially repairing damaged nerves and restoring lost function.
Limitations:
- Intensive Procedure: aHSCT is an intensive treatment that involves chemotherapy, which can lead to severe side effects.
- Uncertainty of Long-Term Effects: While early results are encouraging, the long-term effectiveness of stem cell therapies for MS remains uncertain.
- Limited Access: Access to stem cell therapies is restricted in many countries, with only a few centers offering these treatments, often at a high cost.
Current Research and Clinical Trials
Research on multiple sclerosis treatment with stem cells is ongoing, with several clinical trials worldwide aimed at understanding the best approaches for using stem cells to treat MS. One notable trial, the BEAT-MS study, is comparing aHSCT with the best available disease-modifying therapies (DMTs) for people with relapsing MS. Early results suggest that aHSCT may lead to fewer relapses and reduced disability compared to standard MS treatments.
In Europe, the STAR-MS and RAM-MS trials are examining how aHSCT compares to newer therapies such as alemtuzumab, ocrelizumab, and cladribine. These trials aim to determine which patients are most likely to benefit from stem cell therapy and how it can be used alongside other effective treatments.
Making Decisions About Stem Cell Therapy for MS
When considering multiple sclerosis treatment with stem cells, it is crucial to consult with a neurologist who has expertise in managing MS. Each patient’s circumstances are unique, and decisions about treatment must consider the potential benefits, risks, and individual health conditions.
It is also important to ensure that the clinics offering stem cell therapies are accredited and have substantial experience with the procedures. Stem cell therapy for MS should ideally be conducted within a clinical trial setting, where safety and efficacy can be closely monitored.

Types of Stem Cells Used in MS Treatment
Different types of stem cells are being explored for multiple sclerosis treatment, each with distinct properties and potential applications:
- Hematopoietic Stem Cells (HSCs): Used in aHSCT, HSCs help rebuild the immune system after chemotherapy.
- Mesenchymal Stem Cells (MSCs): MSCs are studied for their ability to reduce inflammation without the need for chemotherapy.
- Neural Stem Cells (NSCs): NSCs may help repair nerve damage in the central nervous system.
- Induced Pluripotent Stem Cells (iPSCs): iPSCs are reprogrammed from adult cells and have the potential to differentiate into various cell types, including nerve cells.
Conclusion
Multiple sclerosis treatment with stem cells is an evolving field that offers hope for patients seeking new ways to manage their condition. While treatments like aHSCT and MSC therapy show promise in reducing inflammation and improving quality of life, more research is needed to fully understand their long-term effects and effectiveness. Consulting with a neurologist and ensuring treatment is received in an accredited setting are essential steps for those considering stem cell therapy. With continued research and clinical trials, the future of MS treatment may include effective stem cell-based therapies that can significantly improve patients’ lives.


